Markets:

Overview

News

Currencies

International

Treasuries

Artelo Biosciences, Inc. - Common Stock (NQ:ARTL)

6.650 -0.390 (-5.54%)

Streaming Delayed Price Updated: 12:46 PM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Artelo Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Artelo Biosciences Stock Doubles After Positive Results In First Non-Opioid Pain Treatment Trial ↗

June 30, 2025

The company said that a multiple ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of ART26.12 with repeated dosing over time is expected to commence in the fourth quarter...

Via Stocktwits

Crude Oil Moves Lower; Joby Aviation Shares Surge ↗

June 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 30, 2025

Via Benzinga

Dow Gains Over 100 Points; Chicago PMI Weakens In June ↗

June 30, 2025

Via Benzinga

Topics Stocks

Recap: Artelo Biosciences Q4 Earnings ↗

March 25, 2024

Via Benzinga

Recap: Artelo Biosciences Q3 Earnings ↗

November 13, 2023

Via Benzinga

Artelo Q2 Net Loss Declines 33% YoY, Here Is What You Need To Know ↗

August 10, 2023

Artelo Biosciences, Inc.

Via Benzinga

Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday? ↗

June 30, 2025

Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in 49 healthy participants.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 30, 2025

Via Benzinga

This UnitedHealth Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

June 11, 2025

Via Benzinga

EXCLUSIVE: Artelo Biosciences' New Peer-Reviewed Research Shows Effectiveness Of Psoriasis Candidate In Animal Models ↗

April 28, 2025

Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia studies.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 14, 2025

Via Benzinga

EXCLUSIVE: Artelo Biosciences Concludes First Cohort Of Healthy Volunteers Of FABP Inhibitor Program ↗

January 13, 2025

Artelo Biosciences advances its pipeline with ART26.12 for neuropathic pain and ART27.13 for cancer-related anorexia, targeting 2025 milestones.

Via Benzinga

ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024 ↗

August 13, 2024

ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q1 2024 ↗

May 13, 2024

ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ARTL Stock Earnings: Artelo Biosciences Misses EPS for Q4 2023 ↗

March 25, 2024

ARTL stock results show that Artelo Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 13, 2023

Via Benzinga

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 07, 2023

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for...

Via Benzinga

Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

September 07, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 07, 2023

We're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 06, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 24, 2023 ↗

August 24, 2023

Via Benzinga

Topics Cannabis

Five Studies Point To Effectiveness Of Artelo Biosciences' CBD Drug Candidate For Cancer Pain – FDA IND Application The Next Step ↗

July 13, 2023

Greg Gorgas, President & CEO of Artelo Biosciences (NASDAQ: ARTL), was recently a guest on Benzinga’s All-Access.

Via Benzinga

Marijuana Stock Movers For August 15, 2023 ↗

August 15, 2023

Via Benzinga

Topics Cannabis

Cannabis Stock Movers For July 24, 2023 ↗

July 24, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.